OLMESARTAN 20mg. IP + HYDROCHLOROTHIAZIDE 12.5mg. IP + AMLODIPINE 5mg. IP

The triple-drug combination that lowers high blood pressure in patients with moderate hypertension is not controlled with dual FDC therapy olmesartan/amlodipine. (Il Suk Sohn, 2016) Lowers blood pressure and reduces the risk of strokes and heart attacks. Decreases blood pressure and enables patients with hypertension to achieve blood pressure goal. (Steven G. Chrysant, 2009) Relaxes the blood vessels so that blood can flow more easily around your body. More effective in reducing blood pressure and achieving blood pressure goals than each of the dual therapies. (Deeks, 2011) Significantly more patients achieve BP goals and targets with the triple combination regimen than with any of the dual combination regimens. (Deeks, 2011) More effective for BP reductions than each of the dual regimens, irrespective of hypertension severity, age, or sex. (Il Suk Sohn, 2016) Provides effective BP reduction in patients whose BP is not controlled with a dual combination of olmesartan/amlodipine. (Il Suk Sohn, 2016) A safe and effective alternative for patients with hypertension not controlled with a dual FDC therapy with olmesartan/amlodipine 20/12.5. (Il Suk Sohn, 2016) A well-tolerated candidate that improves BP control by significantly lowering systolic blood pressure (SBP) and diastolic blood pressure (DBP). (Massimo Volpe L. C., 2012)